Prevalence of Hepatitis C in Liver Cirrhosis Patients
HCV Prevalence in Cirrhosis Patients
DOI:
https://doi.org/10.61919/jhrr.v4i3.1403Keywords:
Cirrhosis, Liver, Hepatitis C, ALT, AST, PCR, Elisa, Viral loadAbstract
Background: Hepatitis C Virus (HCV) is a major cause of chronic liver disease, including liver cirrhosis, globally. Identifying the prevalence of HCV among cirrhotic patients can improve clinical outcomes and guide management strategies.
Objective: To determine the prevalence of HCV in patients with liver cirrhosis and assess the association between liver enzyme levels (ALT and AST) and HCV infection.
Methods: This retrospective observational study was conducted at Fatima Memorial Hospital, Lahore, from June 2023 to December 2023. Fifty liver cirrhosis patients with abnormal liver function tests were included. HCV infection was evaluated using ELISA for antibodies and PCR for RNA detection. Data analysis was performed using IBM SPSS version 25.0, with a p-value of <0.05 considered significant.
Results: Among 50 cirrhotic patients, 60% tested positive for HCV antibodies via ELISA, and 46% were confirmed positive by PCR. Mean ALT levels were significantly higher in ELISA-positive (867 U/L) and PCR-positive (1096.43 U/L) patients compared to ELISA-negative (42 U/L) and PCR-negative (59.96 U/L) patients (p < 0.001).
Conclusion: A significant prevalence of HCV was observed among liver cirrhosis patients, with elevated ALT and AST levels indicating liver damage associated with HCV infection.
Downloads
References
Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13(17):2436-41.
Kalra A, Tuma F, Yetiskul E, Wehrle CJ. Physiology, Liver. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.
Bernal W, Wendon J. Acute Liver Failure. N Engl J Med. 2013;369(26):2525-34.
Trepo C. A Brief History of Hepatitis Milestones. Liver Int. 2013;34(Suppl 1):29-37.
Tanaka T, Shakado S, Takata K, Inomate S, Ueda S, Morihara D, et al. Hepatitis C Infected Patients with Persistently Normal Alanine Aminotransferases Level. Med Bull. 2012;103-12.
Khatri M, Contributors WE. Hepatitis C Transmission. How Hepatitis C Spreads & Contracted. 2022;5-13.
Bashir MF, Haider MS, Rashid N, Riaz S. Association of Biochemical Markers, Hepatitis C Virus. Trop J Med. 2013;1596-9827.
World Health Organization (WHO). Hepatitis C [Internet]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis
Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 21st ed. New York: McGraw Hill Medical; 2020.
World Health Organization (WHO). Hepatitis C [Internet]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis
Cramm JM, Nieboer AP. Disease Management: The Need for a Focus on Broader Self-Management Abilities and Quality of Life. Popul Health Manag. 2015;18(4):246-55.
Firdus R, Sha K, Biswas A, Sadukhan PC. Current Molecular Methods for the Detection of Hepatitis C Virus in High-Risk Group Population: A Systematic Review. 2015;1-13.
Fabrizi F, Lunghi G, Andrulli S, Pagliari B, Mangano S, Farana P, et al. Influence of Hepatitis C Virus Viraemia upon Serum Aminotransferase Activity in Chronic Liver Dialysis Patients. Nephrology. 1997;2(2):1394-8.
Ullah A, Rehman I, Ahmad J, Gohar M, Ahmad S, Ahmad B. Hepatitis C Virus and Cirrhosis: An Overview from Khyber Pakhtunkhwa Province of Pakistan. Viral Immunol. 2020;33(5):396-403.
Dor-Mohammadi T, Daryani NE, Bashashati M, Hashtrudi AA, Haghpanah B, Sayyah AR, et al. Relationship Between Serum Alanine Aminotransferase Levels and Liver Histology in Chronic Hepatitis C-Infected Patients. Indian J Gastroenterol. 2015;24(2):112-8.
Nadeem A, Hussain MA, Aslam M. Correlation of Serum Alanine Aminotransferase and Aspartate Aminotransferase Levels to Liver Histology in Chronic Hepatitis C. Hepatol Res. 2010;20(10):657-61.
Khan AH. Liver Function Tests in Hepatitis C Patients of Local Population of Lahore. Pak Bio Med J. 2022;1:12-6.
Anderson FH, Zaman A, Taylor W, McMahon R, Weltman M, Jeffery H. An Assessment of the Clinical Utility of Serum ALT and AST in Chronic Hepatitis C. Hepatol Res. 2000;18(1):63-71.
Seglen PO. Why the Impact Factor of Journals Should Not Be Used for Evaluating Research. BMJ. 1997;314(7079):497-502.
Cramm JM, Nieboer AP. Disease Management: The Need for a Focus on Broader Self-Management Abilities and Quality of Life. Popul Health Manag. 2015;18(4):246-55.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Muhammad Kashif, Fatima Zaman, Muhammad Hassan Uzman Uzman, Tehreem Shabbir, Nadeem Ul Hassan Khan, Sania Atta, Saleha Shiraz, Muhammad Ali Zahid, Atif Munir
This work is licensed under a Creative Commons Attribution 4.0 International License.
